The objective of the Funding Program is to gain a better understanding of the specific role of dairy products in attaining and maintaining optimum health. DFC considers Funding Applications that have nutritional and health implications for Canadian dairy products and are relevant to Canadian dairy farmers. In addition, DFC has a special interest in encouraging research that will help bring innovative and competitive dairy products with health benefits to the market. Of specific interest to DFC are Funding Applications which feature dairy products in their entirety, demonstrate technological innovation and utilize a multidisciplinary approach, whenever possible, to address fundamental and applied research questions. Applied human randomized, controlled trials and in vivo mechanistic studies are of particular interest.
Deadline for Letter of Intent: December 1, 2016Read More
The purpose and priorities of the 2017 competition are the encouragement of innovations in the assessment of clinical competence or performance of students, postgraduate trainees or practitioners. Priority will be given to proposals that show promise in contributing to the knowledge and understanding of measurement in clinical assessment and to clinical program evaluation methods for medical education. The proposal must focus on research, not development, in the assessment of performance or clinical assessment.
Deadline: February 1, 2017Read More
The foundation offers grants to conduct research that addresses an important and novel, basic or clinical research question related to PSC and closely allied diseases (such as inflammatory bowel diseases (IBD), ulcerative colitis (UC) or Crohn's disease) as they relate to PSC.
Deadline: April 1, 2017Read More
"The Grant-in-Aid (GIA) program, a national peer reviewed application process, supports pulmonary research or development projects and offers grants for research operating costs, including laboratory supplies, technicians and some equipment for up to one or two years (varies from province to province). The Canadian Lung Association (CLA) manages the GIA program application and peer review processes. The provincial lung associations make funding decisions and administer the awards, taking into account application budgets and competition results. "
Deadline for Registration: November 18, 2016Read More
The award supports the exploration of a highly innovative new concept or untested theory that addresses an important problem relevant to epilepsy.
Deadline for letter of intent: November 16, 2016Read More
"Foundation Fighting Blindness and Harrington Discovery Institute have partnered to form The National Center for Excellence in Fighting Blindness, a Gund-Harrington initiative. This initiative is focused on accelerating the translation of research findings in inherited retinal degenerative diseases (IRD) with the ultimate goal of developing new therapies to prevent, treat or cure blindness. The initiative seeks to award Gund-Harrington Scholar Awards that recognize innovators in the United States and Canada whose research has the potential to advance standard of care. The award provides funding for translational drug development and cell therapy along with non-financial project support to help bridge the gap between laboratory-based research and the clinic. Selected projects must demonstrate a reasonable expectation that they can develop a lead product with strong potential for clinical and commercial application by the end of the three year funding period. "
Deadline for letter of intent: October 15, 2016Read More
The Myotubular Trust is looking to fund further projects that will help find a cure and/ or a treatment for any of the three types of myotubular myopathy (congenital X-linked recessive; congenital autosomal recessive; autosomal dominant), focusing on research that would not generally be funded by public or industrial funding sources.
Deadline: November 30, 2016Read More
The GAPP promotes the commercialization and translation of genomics-derived technologies. It provides a unique opportunity for User organizations to leverage their R&D investments with public funding. GAPP fosters academic collaborations with Users from industry, government, not-for-profits, and other organizations. Successful projects are driven by the User and focus on areas of opportunity that they have identified.
Deadline for Expressions of Interest: November 7, 2016Read More
The Progeria Research Foundation awards grants to applicants who seek to conduct research to find the cause, treatment, or cure for Hutchinson-Gilford Progeria Syndrome (Progeria, or HGPS).
Deadline: March 21, 2017Read More
The goal of this funding opportunity is to support research teams which contribute to capacity building efforts in patient-oriented research, as identified in the SPOR Capacity Development Framework, and to catalyze opportunities for clinician scientists (i.e., nurses, occupational therapists, pharmacists, social workers, physiotherapists, psychologist, and other health professionals) to be involved and learn in the context of patient-oriented research teams.
Deadline: December 13, 2016Read More
"The Weston Brain Institute is delighted to launch our Transformational Research 2017 program to fund high-potential translational research projects with excellent preliminary data. "
Deadline for letter of intent: December 12, 2016Read More
The CHS Dream of a Cure Research Program, through funds provided by the Hemophilia Research Million Dollar Club and the Canadian Hemophilia Society, supports research focused on improving the health and the quality of life of all people with inherited bleeding disorders and finding a cure. The CHS invites applicants to apply for basic scientific research grants in fields relevant to hemophilia A and B, von Willebrand disease, rare factor deficiencies, platelet function disorders (and platelet pathophysiology) and other congenital and acquired bleeding disorders.
Deadline: November 15, 2016Read More
This program allows Canadian investigators to conduct research on medical and psychosocial aspects of bleeding disorders, including outcome evaluation. Grants are awarded for clinical research in fields relevant to improving the quality of life for persons with hemophilia, persons with von Willebrand disease or other inherited bleeding disorders, persons with related conditions such as HIV or hepatitis C, and carriers of an inherited bleeding disorder.
Deadline: November 15, 2016Read More
The NPKUA is seeking proposals for pre-clinical, translational, and clinical research projects that investigate all aspects of PKU.
Deadline: November 1, 2016Read More
"With an emphasis on original work that focuses on improving existing analytical methods for detecting particular drugs, developing new analytical methods to test for substances not currently detectable, and discovering cost-effective approaches for testing widely abused substances across all levels of sport, the following areas of investigation reflect the PCC's current research priorities: - Developing methods of cost-effective testing to detect and deter the use of banned and illegal substances. - Developing testing protocols to detect designer substances used for doping purposes. - Improving existing analytical methods to detect particular drugs, ex. GH, IGF-1, EPO, hCG. - Developing analytical methods to detect performance enhancing drugs not currently detectable. - Longitudinal urinary excretion patterns, metabolism and dose-concentration. - Critical reviews to support interpretation of laboratory data. - Alternative specimens, (ex. oral fluid, dried blood/plasma spots) for testing. "
Deadlines for pre-applications: November 1, 2016; March 1, 2017Read More
PERF wishes to promote advances in the field of pediatric epilepsy.
"Deadline for letter of inquiry: December 1, 2016 Deadline for application: March 1, 2017"Read More
Innovation grants have been created to support innovative, creative problem solving in cancer research. As competition for grant funding increases, peer review panels become more conservative and risk averse, emphasizing feasibility more than innovation. The goal of this CCSRI grant program is to support unconventional concepts, approaches or methodologies to address problems in cancer research. Innovation projects will include elements of creativity, curiosity, investigation, exploration and opportunity. Successful projects may be based on "high risk" ideas, but will have the potential for "high reward" (i.e. to significantly impact the understanding of cancer and generate new approaches to combat the disease by introducing novel ideas into use or practice).
Deadlines for Abstract Submission: February 15, 2017
Deadlines for Application: April 01, 2017
The purpose of this funding opportunity is to support teams of researchers and decision makers interested in conducting applied health services and policy research that will be useful to health system managers and/or decision makers in Cancer Control.
Deadline for Letter of Intent: October 18, 2016Read More
"The CIHR Institutes of Infection and Immunity (III) and Population and Public Health (IPPH) in partnership with the Public Health Agency of Canada (PHAC) are offering operating grants on Improved Immunization Coverage Initiative. "
Deadline: December 6, 2016Read More
"The objective of these awards is to provide established researchers with funds to generate sufficient preliminary data to become competitive for funds from other sources, such as the National Institute of Health (NIH). Proposals must be relevant to inflammatory bowel disease (Crohn's Disease or ulcerative colitis)."
Deadlines for Letters of Intent: November 1, 2016; May 1, 2017Read More
"Mitacs is now accepting applications for competitive international research opportunities, including student travel to and from Canada. Projects last 12–24 weeks and are open to graduate students in all disciplines. Select destinations are also open to senior undergraduates. Funding varies by destination. "
Deadline: November 9, 2016Read More
The AFTD and the Alzheimer's Drug Discovery Foundation (ADDF) are pleased to announce a Request for Proposals for The Treat FTD Fund, a new initiative to support clinical trials of new and repurposed drugs for symptomatic or disease-modifying treatment of FTD. Proposals that utilize innovative clinical trials designs, clinical endpoints, or biomarkers are encouraged.
Deadline for letter of intent: November 15, 2016Read More
These awards are expected to provide funds that will support investigators pursuing epidemiological research aimed at improving our understanding of childhood cancer. This grant mechanism is designed to support the research that focuses on the epidemiology, early detection or prevention of childhood cancer; or comparative effectiveness and outcomes research related to detection, prevention and treatment.
Deadline: December 15, 2016Read More
"ALSF is committed to creating opportunities for new and innovative research into treatments and cures for childhood cancers. These grants are designed to provide critical and significant seed funding for experienced investigators with a novel and promising approach to finding causes and cures for childhood cancers. This may represent a change in research direction and/or an innovative new idea that moves away from an investigator's prior research. "
Deadline for Letters of Intent: November 1, 2016Read More
The Preterm Birth Initiative was created to increase the understanding of the biological mechanisms underlying parturition and spontaneous preterm birth. The initiative is designed to stimulate both creative individual scientists and multi-investigator teams to approach the problem of preterm birth using creative basic and translation science methods.
Deadline: December 1, 2016Read More
DTRF funds research that will advance the current scientific knowledge about desmoid tumors, resulting in the development of new treatment options.
Deadline: December 1, 2016Read More
Mini-grants of up to $10,000 are available annually to provide seed funding for pain research projects initiated by trainees registered at UWO. Trainees include Medical Students, Residents, Fellows and Post-graduate students/fellows, and must be sponsored by a member of the Faculty at UWO. Questions regarding this competition should be directed to Dr. Dwight Moulin, firstname.lastname@example.org
Deadline: December 1, 2016Terms of reference
The Translational Research Program (TRP) was developed to encourage and provide early-stage support for clinical research in leukemia, lymphoma and myeloma, which is intended to develop innovative approaches to treatment, diagnosis or prevention.
"Deadline for Letter of Intent: January 13, 2017 Deadline for Applications: March 1, 2017"Read More
Western researchers can consult Pivot, a comprehensive database of grant information.